Efficacy and safety of nivolumab in asian patients with advanced hepatocellular carcinoma (HCC): Subanalysis of the CheckMate 040 Study — Su Pin Choo (2017) | RDL Network
Thomas Yau, Chih‐Hung Hsu, Yoon‐Koo Kang, T. Kim, Ming‐Mo Hou, Ho Yeong Lim, Yee Chao, Y. Kim, Masafumi Ikeda, Su Pin Choo, Jaclyn Neely, Yun Shen, Marina Tschaika, Masatoshi Kudo
Ignacio Melero, Bruno Sangro, Thomas Cheung Yau, Chiun Hsu, Masatoshi Kudo, Todd S. Crocenzi, Tae‐You Kim, Su Pin Choo, Jörg Trojan, Tim Meyer, Theodore H. Welling, Winnie Yeo, Akhil Chopra, Jeffrey Anderson, Christine Marie Dela Cruz, Lixin Lang, Jaclyn Neely, Hao Tang, Anthony B. El-Khoueiry
Ignacio Melero, Anthony B. El-Khoueiry, Thomas Yau, Chiun Hsu, Masatoshi Kudo, Todd S. Crocenzi, Tae‐You Kim, Su Pin Choo, Jörg Trojan, Theodore H. Welling, Yoon‐Koo Kang, Winnie Yeo, Akhil Chopra, Adyb Baakili, Christine Dela Cruz, Huanyu Zhao, Bruno Sangro, Tim Meyer
Todd S. Crocenzi, Anthony B. El-Khoueiry, Thomas Cheung Yau, Ignacio Melero, Bruno Sangro, Masatoshi Kudo, Chiun Hsu, Jörg Trojan, Tae‐You Kim, Su Pin Choo, Tim Meyer, Yoon‐Koo Kang, Winnie Yeo, Akhil Chopra, Adyb Baakili, Christine Marie Dela Cruz, Lixin Lang, Jaclyn Neely, Theodore H. Welling
Discussion(0)
No comments yet. Be the first to comment.